Determinants of Blood Brain-Derived Neurotrophic Factor Blood Levels in Patients with Alcohol Use Disorder

被引:21
|
作者
Nubukpo, Philippe [1 ,2 ]
Ramoz, Nicolas [3 ]
Girard, Murielle [2 ]
Malauzat, Dominique [2 ]
Gorwood, Philip [3 ,4 ]
机构
[1] Ctr Hosp Esquirol, Pole Addictol, Limoges, France
[2] Ctr Hosp Esquirol, Unite Rech & Neurostimulat, 15 Rue Docteur Marcland, F-87025 Limoges, France
[3] INSERM, UMR894, Ctr Psychiat & Neurosci, Paris, France
[4] Univ Paris 05, Hop St Anne, CMME, Paris, France
关键词
Brain-Derived Neurotrophic Factor; Alcohol; Depression; Withdrawal; BDNF VAL66MET POLYMORPHISM; BECK DEPRESSION INVENTORY; GENE POLYMORPHISM; MAJOR DEPRESSION; MET ALLELE; COCAINE; NEUROPLASTICITY; INCREASES; RAT; SCHIZOPHRENIA;
D O I
10.1111/acer.13414
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Blood brain-derived neurotrophic factor (BDNF) levels are influenced by both addiction and mood disorders, as well as somatic conditions, gender, and genetic polymorphisms, leading to widely varying results. Depressive symptoms and episodes are frequently observed in patients with alcohol use disorder, and vary widely over time, making it a challenge to determine which aspects are specifically involved in variations of serum BDNF levels in this population. Methods: We assessed 227 patients with alcohol dependence involved in a detoxification program, at baseline and after a follow-up of 6 months, for the Alcohol Use Disorders Identification Test score, the length of alcohol dependence, and the number of past detoxification programs. The Beck Depression Inventory and information on current tobacco and alcohol use, suicidal ideation, body mass index, age, gender, and psychotropic treatments were also collected. Serum BDNF (ELISA) and 2 genetic polymorphisms of the BDNF gene (Val33Met and rs962369) were analyzed. Results: The presence of the Met allele, 2 markers of the history of alcohol dependence (gamma glutamyl transferase and the number of past treatments in detoxification programs), and the presence of a depressive episode (but not depressive score) were significantly associated with the 2 blood levels of BDNF at baseline and after 6 months. After controlling for baseline BDNF levels, the presence of the Met allele and an ongoing depressive episode were the only variables associated with changes in BNDF levels after 6 months. Conclusions: Low serum BDNF levels are associated with characteristics related to alcohol consumption and mood disorders, and variants of the BDNF gene in alcohol use disorder patients. The factors that most strongly influenced changes in serum BDNF levels following treatment in an alcohol detoxification program were variants of the BDNF gene and ongoing depression.
引用
收藏
页码:1280 / 1287
页数:8
相关论文
共 50 条
  • [41] Brain-Derived Neurotrophic Factor in Autism Spectrum Disorder
    Fluegge, Keith
    JAMA PEDIATRICS, 2017, 171 (05) : 492 - 493
  • [42] Decreased Serum Brain-Derived Neurotrophic Factor Levels in Seizure Patients
    Leaver, Katherine E.
    LaFrance, W. Curt, Jr.
    ANNALS OF NEUROLOGY, 2009, 66 : S16 - S16
  • [43] Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients
    Brunoni, A. R.
    Lotufo, P. A.
    Sabbag, C.
    Goulart, A. C.
    Santos, I. S.
    Bensenor, I. M.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (08) : 711 - 714
  • [44] Maternal generalized anxiety disorder during pregnancy and fetal brain development: A comparative study on cord blood brain-derived neurotrophic factor levels
    Uguz, Faruk
    Sonmez, Erdem Onder
    Sahingoz, Mine
    Gokmen, Zeynel
    Basaran, Mustafa
    Gezginc, Kazim
    Sonmez, Gulsum
    Kaya, Nazmiye
    Erdem, Sami Sait
    Cicekler, Humeyra
    Tasyurek, Erkan
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2013, 75 (04) : 346 - 350
  • [45] Various levels of plasma brain-derived neurotrophic factor in patients with tinnitus
    Goto, Fumiyuki
    Saruta, Juri
    Kanzaki, Sho
    To, Masahiro
    Tsutsumi, Tomoko
    Tsukinoki, Keiichi
    Ogawa, Kaoru
    NEUROSCIENCE LETTERS, 2012, 510 (02) : 73 - 77
  • [46] Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women
    Kenna, Heather A.
    Reynolds-May, Margaret
    Stepanenko, Aleksandra
    Ketter, Terence A.
    Hallmayer, Joachim
    Rasgon, Natalie L.
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 156 : 214 - 218
  • [47] Decreased brain-derived neurotrophic factor (BDNF)- and β-thromboglobulin (β-TG)-blood levels in Alzheimer's disease
    Laske, Christoph
    Stransky, Elke
    Leyhe, Thomas
    Eschweiler, Gerhard W.
    Schott, Klaus
    Langer, Harald
    Gawaz, Meinrad
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (01) : 102 - 103
  • [48] Aquarobic exercises improve the serum blood irisin and brain-derived neurotrophic factor levels in elderly women
    Kim, Ji-Hyeon
    Kim, Do-Yeon
    EXPERIMENTAL GERONTOLOGY, 2018, 104 : 60 - 65
  • [49] Is Blood Brain-Derived Neurotrophic Factor a Useful Biomarker to Monitor Mild Cognitive Impairment Patients?
    Balietti, Marta
    Giuli, Cinzia
    Casoli, Tiziana
    Fabbietti, Paolo
    Conti, Fiorenzo
    REJUVENATION RESEARCH, 2020, 23 (05) : 411 - 419
  • [50] Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): A systematic review and meta-analysis
    Mojtabavi, Helia
    Saghazadeh, Amene
    van den Heuvel, Leigh
    Bucker, Joana
    Rezaei, Nima
    PLOS ONE, 2020, 15 (11):